A NEW assessment tool from the International Pharmaceutical Federation (FIP) encourages regulators to ensure pharmacy is supported in preventing harm from substandard and falsified (SF) medicines in many countries.
"FIP is seriously concerned about the ever-increasing risk to public health of SF pharmaceutical products," said Brett Simmonds, FIP Regulators Advisory Group chair.
"We know that, in some countries, legislation governing the manufacture and distribution of medical products, or the enforcement of legislation, is either non-existent or ineffective.
"FIP has been speaking out against SF medical products for over 20 years and this self-assessment tool is another mechanism to decrease the harmful impact of SF medical products on patient care," commented Simmonds.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Nov 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Nov 23
